MedPage Today1 天
Why Did a GLP-1 Receptor Agonist Fail This Parkinson's Trial?
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.
Yardbarker3 天
Rating Super Bowl angst of AFC fan bases
Ahead of Sunday's Super Bowl between the Philadelphia Eagles and Kansas City Chiefs, Yardbarker NFL writers rate the Super ...